Literature DB >> 4604093

Anaerobic bacteria in late infections after total hip arthroplasty.

C Kamme, L Lidgren, L Lindberg, P A Mårdh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4604093     DOI: 10.3109/inf.1974.6.issue-2.10

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


× No keyword cloud information.
  8 in total

1.  A case of Propionibacterium acnes spinal osteomyelitis.

Authors:  F Suter; M A Silanos; G Tabacchi; F Maggiolo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

2.  Anaerobic and aerobic skin bacteria before and after skin-disinfection with chlorhexidine: an experimental study in volunteers.

Authors:  M L Nielsen; D Raahave; J G Stage; T Justesen
Journal:  J Clin Pathol       Date:  1975-10       Impact factor: 3.411

3.  Deep infection after primary hip arthroplasty: results after treatment of 10 patients.

Authors:  M Breddam; T B Hansen; P B Thomsen
Journal:  Eur J Orthop Surg Traumatol       Date:  1996-05

4.  Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratories.

Authors:  J B Kurtz; P P Mortimer; P R Mortimer; P Morgan-Capner; M S Shafi; G B White
Journal:  J Hyg (Lond)       Date:  1980-04

5.  Airborne non-sporeforming anaerobic bacteria.

Authors:  A Hambraeus; E Benediktsdóttir
Journal:  J Hyg (Lond)       Date:  1980-04

6.  Propionibacterium acnes osteomyelitis: case report and review of the literature.

Authors:  R C Noble; S B Overman
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

7.  Septic arthritis due to Bacteroides fragilis in a wrist affected by rheumatoid arthritis.

Authors:  C A Hart; V M Godfrey; J C Woodrow; A Percival
Journal:  Ann Rheum Dis       Date:  1982-12       Impact factor: 19.103

8.  Penetration into bone and tissues of clindamycin phosphate.

Authors:  P Baird; S Hughes; M Sullivan; I Willmot
Journal:  Postgrad Med J       Date:  1978-02       Impact factor: 2.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.